Article

Capsular Contracture: A Comprehensive Overview

Capsular contracture is a recognized complication across various types of implant-based reconstructive and cosmetic surgeries. It involves the formation of abnormal scar tissue (a fibrous capsule) around an implanted device, leading to potential distortion in shape, firmness, pain, or asymmetry.

Definition

The body naturally forms a collagen capsule around implants during wound healing. This initial capsule is typically thin and flexible. However, it can become pathological through various triggers, resulting in excessive tightening (contraction). The term "capsular contracture" specifically refers to this pathological response where the scar tissue excessively remodels towards contraction.

Symptoms and Grading

Capsular contracture severity is assessed using a classification system known as the Baker Scale:

Baker Grades

  • Grade I: Soft buttocks, normal appearance. No issues.
  • Grade II: Firmness upon touch; generally natural appearance.
  • Grade III (Hard): Palpable hardness in all directions; visible distortion occurs (e.g., wrinkling, shape change).
  • Grade IV: Implant is visibly apparent or fully extruded through the overlying tissue.

This grading system applies to both gluteal and breast implants. Symptoms can range from subtle changes ("iron band" feeling) to significant pain and ptosis (drooping). Distortion refers specifically to a noticeable change in buttock shape, while firmness/pain relates more generally to discomfort or altered tactile sensation.

Grading and Management Correlation

The Baker grades are crucial for determining the appropriate management strategy. For instance:

  • Mild cases (Grade I or II) often allow observation.
  • Moderate cases might require further evaluation and non-surgical options like massage, steroid injections, or external energy modalities.
  • Severe contracture typically necessitates surgical intervention.

Pathophysiology

The development of capsular contracture involves complex mechanisms. The initial capsule formation is a normal physiological response to the presence of an implant. This process becomes pathological due to factors including:

  • Bacterial Biofilms: Communities of bacteria (e.g., Staphylococcus epidermidis, Cutibacterium acnes) encased in a protective matrix adhering to implant surfaces can trigger chronic inflammation and exaggerated foreign body reactions.
  • Hematoma/Seroma: Bleeding or fluid accumulation during surgery provides a favorable environment for inflammation and capsule formation.
  • Surgical Trauma/Mechanical Protection: Insufficient coverage by surrounding muscle tissue (as seen in subglandular placements) can leave the implant exposed to inflammatory factors, increasing risk. Specific placement techniques are tailored to mitigate this exposure.

Risk Factors

Several factors increase the likelihood of developing capsular contracture:

Placement Techniques

Different surgical pocket depths and types influence risk:

  • Subglandular: Placing implants under mammary/fat gland tissue offers least muscle coverage, which is a known risk factor.
  • Submuscular/Under Muscle: Placing implants beneath the pectoral muscle (or gluteal muscles) provides more mechanical protection and potentially reduces exposure to inflammatory elements compared to subglandular placement.

Incision Types

The type of incision used can also impact contracture development, particularly in breast procedures. Periareolar incisions might carry a slightly higher risk than inframammary approaches due to potential increased bacterial exposure or inflammatory response at the wound site if not managed carefully.

Prevention Strategies

Preventing capsular contracture requires careful surgical technique and adherence to principles aimed at minimizing inflammation:

  • Meticulous Hemostasis: Reducing bleeding during surgery decreases hematoma formation, a key trigger.
  • No-Touch Insertion Techniques: Minimizing direct handling of the implant by surgeons (using insertion tools) can help reduce trauma-induced inflammation and biofilm risk.

Management

Non-Surgical Treatments

For mild cases (Baker Grade I or II), non-surgical approaches may be effective:

  • Massage protocols to soften the capsule.
  • External energy modalities like ultrasound therapy. Limited evidence supports adjunctive use of leukotriene inhibitors, though they are sometimes used off-label.

Surgical Management

Surgery is typically indicated for moderate-to-severe contractures (Grades II-IV), especially when accompanied by pain or significant distortion:

  • Capsulectomy: Removal of the pathological scar tissue.
  • Implant Exchange/Surgical Revision: Often involves replacing the existing implant(s) with new ones and may include capsulorplasty (remodeling the remaining capsule).

Related Topics